Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Melon, in the context of drug development and dietary supplements, refers to various types of fruits or their extracts, such as bitter melon (Momordica charantia), watermelon (Citrullus lanatus), and Melon Manis Terengganu. These natural products are being investigated for a range of potential health benefits. Watermelon, through its L-citrulline content, is studied for its impact on blood pressure by influencing nitric oxide production. Bitter melon is extensively researched for its antidiabetic properties, including effects on glycemic regulation, insulin secretion, glucose utilization, and inhibition of enzymes like alpha-glucosidase and dipeptidyl peptidase-4 (DPP-4). It also shows promise in stimulating glucagon-like peptide-1 (GLP-1) secretion, antimalarial activity, and anti-obesity effects, particularly from its seed oil. Melon Manis Terengganu peel powder has been explored for improving glycemic response, and melon oil for skin condition improvement. These substances are typically administered orally as juices, extracts, powders, or capsules, often as dietary supplements or components within herbal formulations.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on melon.